Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry

Detalhes bibliográficos
Autor(a) principal: Paulo Bastos Tigre
Data de Publicação: 2016
Outros Autores: Caio Victor Machado França do Nascimento, Laís Silveira Costa
Tipo de documento: Artigo
Idioma: eng
por
Título da fonte: Cadernos de Saúde Pública
Texto Completo: https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6213
Resumo: The Brazilian pharmaceutical industry is heavily dependent on external sources of inputs, capital, and technology. However, the emergence of technological opportunities and the development of biotechnology and the decline of the patent boom and resulting advances by generic drugs have opened windows of opportunities for the local industry. The article examines the Brazilian industry's innovative behavior vis-à-vis these opportunities, showing that although the industry as a whole invests little in innovation, a few large Brazilian companies have expanded their market share and stepped up their investments in research and development, supported by public policies for innovation.
id FIOCRUZ-5_67b25df16823ee7292e7313d749957ba
oai_identifier_str oai:ojs.teste-cadernos.ensp.fiocruz.br:article/6213
network_acronym_str FIOCRUZ-5
network_name_str Cadernos de Saúde Pública
repository_id_str
spelling Windows of opportunities and technological innovation in the Brazilian pharmaceutical industryJanelas de oportunidades e inovação tecnológica na indústria brasileira de medicamentosDrug IndustryGeneric DrugsSustainable DevelopmentInnovationIndústria FarmacêuticaMedicamentos GenéricosDesenvolvimento SustentávelInovaçãoThe Brazilian pharmaceutical industry is heavily dependent on external sources of inputs, capital, and technology. However, the emergence of technological opportunities and the development of biotechnology and the decline of the patent boom and resulting advances by generic drugs have opened windows of opportunities for the local industry. The article examines the Brazilian industry's innovative behavior vis-à-vis these opportunities, showing that although the industry as a whole invests little in innovation, a few large Brazilian companies have expanded their market share and stepped up their investments in research and development, supported by public policies for innovation.La industria farmacéutica brasileña se caracteriza por su gran dependencia de fuentes externas de insumos, capital y tecnología. El surgimiento de oportunidades tecnológicas, asociadas al desarrollo de la biotecnología, y al fin del boom de las patentes -con el consecuente avance de los medicamentos genéricos-, es paralelo a la apertura de ventanas de oportunidad para la industria local. Este artículo examina el comportamiento innovador de la industria brasileña a la luz de esas oportunidades, revelando que, aunque el conjunto de la industria mantenga bajos niveles de inversión en innovación, un pequeño grupo de grandes empresas nacionales está ampliando su participación en el mercado e intensificando sus inversiones en pesquisa y desarollo, apoyados por políticas públicas de innovación.A indústria farmacêutica brasileira caracteriza-se pela grande dependência de fontes externas de insumos, capital e tecnologia. O surgimento de oportunidades tecnológicas, associadas ao desenvolvimento da biotecnologia e ao fim do boom das patentes com o consequente avanço dos medicamentos genéricos, entretanto, vem abrindo janelas de oportunidades para a indústria local. Este artigo examina o comportamento inovador da indústria brasileira à luz dessas oportunidades, revelando que, embora o conjunto da indústria mantenha baixos níveis de investimentos em inovação, um pequeno grupo de grandes empresas nacionais vem ampliando sua participação no mercado e intensificando seus investimentos em pesquisa e desenvolvimento, apoiados por políticas públicas de inovação.Reports in Public HealthCadernos de Saúde Pública2016-11-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmltext/htmlapplication/pdfapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6213Reports in Public Health; Vol. 32 No. 14 (2016): Supplement 2Cadernos de Saúde Pública; v. 32 n. 14 (2016): Suplemento 21678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZengporhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6213/13156https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6213/13157https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6213/13158https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6213/13159Paulo Bastos TigreCaio Victor Machado França do NascimentoLaís Silveira Costainfo:eu-repo/semantics/openAccess2024-03-06T15:29:12Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/6213Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:07:05.934035Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true
dc.title.none.fl_str_mv Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry
Janelas de oportunidades e inovação tecnológica na indústria brasileira de medicamentos
title Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry
spellingShingle Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry
Paulo Bastos Tigre
Drug Industry
Generic Drugs
Sustainable Development
Innovation
Indústria Farmacêutica
Medicamentos Genéricos
Desenvolvimento Sustentável
Inovação
title_short Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry
title_full Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry
title_fullStr Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry
title_full_unstemmed Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry
title_sort Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry
author Paulo Bastos Tigre
author_facet Paulo Bastos Tigre
Caio Victor Machado França do Nascimento
Laís Silveira Costa
author_role author
author2 Caio Victor Machado França do Nascimento
Laís Silveira Costa
author2_role author
author
dc.contributor.author.fl_str_mv Paulo Bastos Tigre
Caio Victor Machado França do Nascimento
Laís Silveira Costa
dc.subject.por.fl_str_mv Drug Industry
Generic Drugs
Sustainable Development
Innovation
Indústria Farmacêutica
Medicamentos Genéricos
Desenvolvimento Sustentável
Inovação
topic Drug Industry
Generic Drugs
Sustainable Development
Innovation
Indústria Farmacêutica
Medicamentos Genéricos
Desenvolvimento Sustentável
Inovação
description The Brazilian pharmaceutical industry is heavily dependent on external sources of inputs, capital, and technology. However, the emergence of technological opportunities and the development of biotechnology and the decline of the patent boom and resulting advances by generic drugs have opened windows of opportunities for the local industry. The article examines the Brazilian industry's innovative behavior vis-à-vis these opportunities, showing that although the industry as a whole invests little in innovation, a few large Brazilian companies have expanded their market share and stepped up their investments in research and development, supported by public policies for innovation.
publishDate 2016
dc.date.none.fl_str_mv 2016-11-03
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6213
url https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6213
dc.language.iso.fl_str_mv eng
por
language eng
por
dc.relation.none.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6213/13156
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6213/13157
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6213/13158
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6213/13159
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
text/html
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
dc.source.none.fl_str_mv Reports in Public Health; Vol. 32 No. 14 (2016): Supplement 2
Cadernos de Saúde Pública; v. 32 n. 14 (2016): Suplemento 2
1678-4464
0102-311X
reponame:Cadernos de Saúde Pública
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos de Saúde Pública
collection Cadernos de Saúde Pública
repository.name.fl_str_mv Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br
_version_ 1798943382468296704

Registros relacionados